Your session is about to expire
← Back to Search
Procedure
Ultrasound Group for Coronavirus (UNITE Trial)
N/A
Waitlist Available
Research Sponsored by Imanuel Lerman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to date of recovery, assessed up to 6 months
Awards & highlights
UNITE Trial Summary
UNITE Study (UCSD-SW) for COVID-19
Eligible Conditions
- Coronavirus
UNITE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to date of recovery, assessed up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to date of recovery, assessed up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CRP
IL-1β
IL-6 Change
Secondary outcome measures
Change in time to recovery
Other outcome measures
Change in D-dimer levels
Change in death rate
Change in duration of hypoxemia
+7 moreUNITE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Ultrasound GroupExperimental Treatment1 Intervention
Daily ultrasound application to the spleen of approximately 18 minutes for up to 7 days, in addition to standard clinical care.
Group II: Control GroupActive Control1 Intervention
Control Group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Splenic Ultrasound
2021
N/A
~80
Find a Location
Who is running the clinical trial?
Imanuel LermanLead Sponsor
SecondWave Systems Inc.Industry Sponsor
3 Previous Clinical Trials
87 Total Patients Enrolled
MCDC (Unites States Department of Defense)UNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger